FBInvestor
Funds / Defilade Capital Management, L.P.
Institutional Fund

Defilade Capital Management, L.P.

Emeryville, CACIK 20885572 filings on record

Portfolio Value
$712.18M
Q1 2026
Holdings
31
Reported positions
New Buys
9
Opened this quarter
QoQ Change
-3.5%
from $737.73M

Portfolio Value Trend

Reported 13F value by quarter

Portfolio value trend — upgrade to see history

Upgrade

Top Allocations

Largest positions by weight

  • Zimmer Biomet Holdings Inc7.4%
  • Henry Schein Inc6.5%
  • Becton Dickinson & Co6.2%
  • Ptc Therapeutics Inc5.8%
  • Dexcom Inc4.8%
  • Icu Med Inc4.6%
  • Other64.9%

Portfolio Holdings

31 positions · Q1 2026

#SecuritySharesValue% Port.Δ SharesActivity
1Zimmer Biomet Holdings Inc579.2K$52.37M7.4%+579.2KNew
2Henry Schein Inc624.0K$45.99M6.5%+303.6KAdded
3Becton Dickinson & Co279.2K$43.90M6.2%+198.0KAdded
4Ptc Therapeutics Inc376.2K$41.11M5.8%+376.2KNew
5Dexcom Inc538.8K$33.83M4.8%+293.9KAdded
6Icu Med Inc254.3K$32.84M4.6%86.5KReduced
7Insmed Inc194.9K$31.87M4.5%+144.9KAdded
8Intuitive Surgical Inc67.7K$31.20M4.4%+22.0KAdded
9Revolution Medicines Inc316.0K$30.73M4.3%47.5KReduced
10Globus Med Inc354.4K$30.53M4.3%+87.1KAdded

21 more holdings on Premium

See this fund's complete portfolio, full position changes, and activity history.

Unlock full portfolio